Free Trial

Clearside Biomedical (CLSD) Insider Trading & Ownership

Clearside Biomedical logo
$1.05 +0.02 (+1.94%)
(As of 11/20/2024 ET)

Clearside Biomedical (NASDAQ:CLSD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.20%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$728,031.93
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$39,372.00
Get CLSD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Clearside Biomedical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CLSD Insider Buying and Selling by Quarter

Clearside Biomedical Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/1/2024Ngai Hang Victor ChongInsiderBuy36,500$1.00$36,500.00  
6/24/2024Ngai Hang Victor ChongInsiderBuy23,500$1.06$24,910.00  
5/15/2024Benjamin R YerxaDirectorBuy7,813$1.31$10,235.03  
4/17/2024Anthony S GibneyDirectorBuy6,710$1.25$8,387.50  
3/20/2024Ngai Hang Victor ChongInsiderBuy30,000$1.60$48,000.00  
2/7/2024Bradford T WhitmoreMajor ShareholderBuy444,444$1.35$599,999.40  
1/19/2024Charles A DeignanCFOSell12,900$1.28$16,512.00  
1/19/2024George M LasezkayCEOSell18,000$1.27$22,860.00  
(Data available from 1/1/2013 forward)

CLSD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Clearside Biomedical includes Anthony S Gibney, Benjamin R Yerxa, Bradford T Whitmore, Charles A Deignan, Clay Thorp, George M Lasezkay, Nancy J Hutson, Ngai Hang Victor Chong, and Thomas Ciulla. Learn more on insiders at CLSD.

9.20% of Clearside Biomedical stock is owned by insiders. Learn more on CLSD's insider holdings.

The following insiders have purchased CLSD shares in the last 24 months: Anthony S Gibney ($8,387.50), Benjamin R Yerxa ($10,235.03), Bradford T Whitmore ($648,044.24), Clay Thorp ($22,880.00), Nancy J Hutson ($8,600.00), and Ngai Hang Victor Chong ($109,410.00).

Insiders have purchased a total of 647,933 CLSD shares in the last 24 months for a total of $807,556.77 bought.

The following insiders have sold CLSD shares in the last 24 months: Charles A Deignan ($37,557.00), George M Lasezkay ($52,103.80), and Thomas Ciulla ($23,654.40).

Insiders have sold a total of 80,830 Clearside Biomedical shares in the last 24 months for a total of $113,315.20 sold.

Clearside Biomedical Key Executives

  • Dr. George M. Lasezkay J.D. (Age 72)
    Pharm.D., Pharma.D., President, CEO & Director
    Compensation: $836.15k
  • Mr. Charles A. DeignanMr. Charles A. Deignan (Age 60)
    Chief Financial Officer
    Compensation: $568.68k
  • Dr. Thomas A. Ciulla M.B.A. (Age 59)
    M.D., Chairman of Scientific Advisory Board
    Compensation: $531.52k
  • Ms. Jenny R. Kobin (Age 57)
    Head of Investor Relations
  • Mr. Rick McElheny
    Senior Vice President of Corporate Development & Alliance Management
  • Mr. Rafael V. Andino (Age 59)
    Senior Vice President of Engineering & Manufacturing
  • Ms. Susan L. Coultas Ph.D.
    Chief Clinical Officer
  • Dr. Ngai Hang Chong FRCOphth
    M.D., Chief Medical Officer
  • Mr. Leslie B. Zacks (Age 55)
    Secretary


This page (NASDAQ:CLSD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners